FDA: Forest Labs Lung Drug Effective For COPD; Raises Concerns – NASDAQ

Forest is seeking FDA approval for aclidinium bromide, a long-acting inhaled drug developed for the treatment of COPD. Forest licensed the U.S. rights for the product from Almirall S.A. (ALM.MC). Aclidinium will be reviewed on Thursday by FDA’s …

Leave a Reply

Your email address will not be published. Required fields are marked *